A detailed history of J.Safra Asset Management Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 203 shares of LEGN stock, worth $6,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
203
Previous 31 554.84%
Holding current value
$6,520
Previous $1,000 500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$32.61 - $44.32 $5,608 - $7,623
172 Added 554.84%
203 $6,000
Q2 2025

Oct 29, 2025

BUY
$27.69 - $37.91 $249 - $341
9 Added 4.69%
201 $7,000
Q2 2025

Jul 28, 2025

BUY
$27.69 - $37.91 $83 - $113
3 Added 10.71%
31 $1,000
Q1 2025

Oct 29, 2025

SELL
$31.43 - $39.7 $345 - $436
-11 Reduced 5.42%
192 $6,000
Q3 2024

Nov 13, 2024

BUY
$43.55 - $59.88 $1,219 - $1,676
28 New
28 $1,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.38B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.